+ National World Politics Business Sports Auto & Tech Entertainment Lifestyle & Health Videos Opinion In-Short Women Legally Speaking Statistically Speaking Medically Speaking Art & Culture Spirituality Society & Living Foodie e-Paper
HOME» Tag » Over 30% of Covaxin Recipients Experienced Health Issues After One Year “Safety is primary focus for all our vaccines”: Covaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine Centre To Delhi High Court: Not Permissible To Take One Dose Of Covishield And Another Of Covaxin DGCI Approves Covovax In Markets iNCOVACC nasal Covid vaccine will cost Rs 800 for private, Rs 325 for govt hospitals AFTER PFIZER & SII, BHARAT BIOTECH SEEKS EMERGENCY USE NOD FOR COVID VACCINE LOAD MORE No More
Advertisement White House: Quad Group Now More Strategically Aligned And Relevant Than Ever Bengaluru Pubs Are Perfect for Kids, American Mom Reveals Why US Student Dhruvi Patel Crowned Miss India Worldwide 2024 Watch: Israeli Soldiers Allegedly Throw Lifeless Bodies From Rooftop In West Bank This Noida Singer Becomes First To Own iPhone 16 In Delhi-NCR Work Days Required to Buy the iPhone 16 : A Global Affordability Insights India Extends Financial Support to Maldives with Rollover of Treasury Bill Advertisement